The University of Texas at San Antonio
UT Health San Antonio researchers have teased out why some lipids spike in the brains of people with Alzheimer's disease and what that may mean for cognitive function, revealing a new target for potential treatments.
-
The death from bird flu of a person in Washington is a reminder that avian flu is circulating widely during flu season, increasing the potential for the emergence of a bird flu strain that can spread easily between humans. -
A newly constructed center for studying and treating diseases of the brain will open in San Antonio at the end of the year. The Center for Brain Health could revolutionize how we understand disorders like Alzheimer's, Parkinson's, and ALS. -
People who live near the Houston Ship Channel live shorter, unhealthier lives than those who don't. One scientist has dedicated his career to understanding and exposing the threat, under great pressure to stay silent. We'll meet The Scientist Who Refused To Be Intimidated. -
Up to 20% of all new mothers experience some degree of postpartum depression. That number spikes to up to 40% of Latina or Hispanic and Black mothers. -
This year's version of H3N2 has experts on alert. It's a mutated version, subclade K, that may weaken the vaccine's protection, but makes getting vaccinated more important than ever. -
A San Antonio doctor who uses endoscopy to treat people who are too sick to survive surgery has become the first Texan to be named a Master Endoscopist by the American Society for Gastrointestinal Endoscopy.
-
A San Antonio sleep disorder and PTSD researcher uses cognitive behavioral therapy to reduce the frequency and intensity of nightmares.
-
The dementia fund’s approval comes at a critical moment for Texas, which ranks second in the nation in Alzheimer’s deaths and third in the disease’s prevalence. The need for intervention is especially high in the Rio Grande Valley — a four-county region along the Texas-Mexico border that’s become the epicenter of a nationwide Alzheimer’s spike. -
The 103,000-square-foot facility is the new home of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. -
A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor at UT Southwestern Medical Center explains.
